Article History
Accepted: 17 February 2023
First Online: 16 March 2023
Competing interests
: D.C. is theĀ President of FACIT.org, which owns and distributes two of the patient-reported outcome measures discussed in the article (FACT-GĀ and FKSI). D.C. has received consulting honoraria from Bristol-Myers Squibb, Ipsen, Pfizer, Merck and Novartis, and has received research funding to his institution from Bristol-Myers Squibb, Pfizer and Merck; these companies sponsored or collaborated on the following clinical trials discussed in the article: CheckMate 214, JAVELIN Renal 101, CLEAR, KEYNOTE-426 and CheckMate 9ER. The other authors declare no competing interests.